Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach

Johannes Levin^{1

2}, Sylvia Maaß^{3

4}, Madeleine Schuberth⁵, Gesine Respondek^{3

4}, Friedemann Paul^{6

7}, Ullrich Mansmann⁸, Wolfgang H Oertel⁹, Stefan Lorenzl^{5

10}, Florian Krismer¹¹, Klaus Seppi¹¹, Werner Poewe¹¹, Gregor Wenning¹¹, D Berg¹², Joseph Claßen¹³, Georg Ebersbach¹⁴, Karla Eggert¹⁵, Jan Kassubek¹⁶, Axel Lipp¹⁷, Matthias Löhle¹⁸, Brit Mollenhauer^{19

20}, Alexander Münchau²¹, Martin Südmeyer²², C Blankenstein²³, C Eberhardt²⁴, B Ertl-Wagner²⁵, H Heise²⁶, I Ricard²⁷; PROMESA study group; Armin Giese²⁸, Kai Bötzel⁵, Günter Höglinger^{3

4}

Affiliations

¹ Department of Neurology, Klinikum Großhadern, Ludwig-Maximilians-Universität, Munich, Germany. jlevin@med.uni-muenchen.de.
² German Centre for Neurodegenerative Diseases (DZNE), Feodor-Lynen Str. 17, 81377, Munich, Germany. jlevin@med.uni-muenchen.de.
³ German Centre for Neurodegenerative Diseases (DZNE), Feodor-Lynen Str. 17, 81377, Munich, Germany.
⁴ Department of Neurology, Klinikum Rechts der Isar, Technical University, Munich, Germany.
⁵ Department of Neurology, Klinikum Großhadern, Ludwig-Maximilians-Universität, Munich, Germany.
⁶ NeuroCure Clinical Research Center and Clinical and Experimental Multiple Sclerosis Research Center, Department of Neurology, Charité University Medicine Berlin, Berlin, Germany.
⁷ Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité University Medicine Berlin, Berlin, Germany.
⁸ Institute for Medical Informatics, Biometry and Epidemiology (IBE), Ludwig-Maximilians-Universität, Munich, Germany.
⁹ Department of Neurology, Philipps Universität, Marburg, Germany.
¹⁰ Institute of Nursing Science and Practice, Paracelsus Medical University, Salzburg, Austria.
¹¹ Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
¹² Department of Neurodegeneration, Center of Neurology, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
¹³ Department of Neurology, University of Leipzig, Leipzig, Germany.
¹⁴ Movement Disorders Clinic, Beelitz-Heilstätten, Germany.
¹⁵ Universitätsklinikum Giessen und Marburg, Klinik für Neurologie, Marburg, Germany.
¹⁶ Department of Neurology, University of Ulm, Ulm, Germany.
¹⁷ Department of Neurology, Charité-University Medicine Berlin, Berlin, Germany.
¹⁸ Department of Neurology, Technische Universität Dresden, Dresden, Germany.
¹⁹ Paracelsus-Elena-Klinik, Kasel, Germany.
²⁰ University Medical Center, Georg-August-Universität Göttingen, Göttingen, Germany.
²¹ Department of Pediatric and Adult Movement Disorders and Neuropsychiatry, Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
²² Institute of Clinical Neuroscience and Medical Psychology, Heinrich-Heine-University, Medical Faculty, Düsseldorf, Germany.
²³ Münchner Studienzentrum (MSZ), Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
²⁴ Pharmacy, Charité-University Medicine Berlin, Berlin, Germany.
²⁵ Institute for Clinical Radiology, Ludwig-Maximilians-University Munich, Munich, Germany.
²⁶ Clinical Study Center, Ludwig-Maximilians-Universität München, Munich, Germany.
²⁷ Institute of Medical Informatics, Biometry, and Epidemiology, University of Munich, Munich, Germany.
²⁸ Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität, Munich, Germany.

PMID: 27562771
DOI: 10.1007/s00702-016-1602-x

Published Erratum

Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach

Johannes Levin et al. J Neural Transm (Vienna). 2016 Nov.

. 2016 Nov;123(11):1357-1358.

doi: 10.1007/s00702-016-1602-x.

Authors

Affiliations

¹ Department of Neurology, Klinikum Großhadern, Ludwig-Maximilians-Universität, Munich, Germany. jlevin@med.uni-muenchen.de.
² German Centre for Neurodegenerative Diseases (DZNE), Feodor-Lynen Str. 17, 81377, Munich, Germany. jlevin@med.uni-muenchen.de.
³ German Centre for Neurodegenerative Diseases (DZNE), Feodor-Lynen Str. 17, 81377, Munich, Germany.
⁴ Department of Neurology, Klinikum Rechts der Isar, Technical University, Munich, Germany.
⁵ Department of Neurology, Klinikum Großhadern, Ludwig-Maximilians-Universität, Munich, Germany.
⁶ NeuroCure Clinical Research Center and Clinical and Experimental Multiple Sclerosis Research Center, Department of Neurology, Charité University Medicine Berlin, Berlin, Germany.
⁷ Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité University Medicine Berlin, Berlin, Germany.
⁸ Institute for Medical Informatics, Biometry and Epidemiology (IBE), Ludwig-Maximilians-Universität, Munich, Germany.
⁹ Department of Neurology, Philipps Universität, Marburg, Germany.
¹⁰ Institute of Nursing Science and Practice, Paracelsus Medical University, Salzburg, Austria.
¹¹ Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
¹² Department of Neurodegeneration, Center of Neurology, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
¹³ Department of Neurology, University of Leipzig, Leipzig, Germany.
¹⁴ Movement Disorders Clinic, Beelitz-Heilstätten, Germany.
¹⁵ Universitätsklinikum Giessen und Marburg, Klinik für Neurologie, Marburg, Germany.
¹⁶ Department of Neurology, University of Ulm, Ulm, Germany.
¹⁷ Department of Neurology, Charité-University Medicine Berlin, Berlin, Germany.
¹⁸ Department of Neurology, Technische Universität Dresden, Dresden, Germany.
¹⁹ Paracelsus-Elena-Klinik, Kasel, Germany.
²⁰ University Medical Center, Georg-August-Universität Göttingen, Göttingen, Germany.
²¹ Department of Pediatric and Adult Movement Disorders and Neuropsychiatry, Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
²² Institute of Clinical Neuroscience and Medical Psychology, Heinrich-Heine-University, Medical Faculty, Düsseldorf, Germany.
²³ Münchner Studienzentrum (MSZ), Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
²⁴ Pharmacy, Charité-University Medicine Berlin, Berlin, Germany.
²⁵ Institute for Clinical Radiology, Ludwig-Maximilians-University Munich, Munich, Germany.
²⁶ Clinical Study Center, Ludwig-Maximilians-Universität München, Munich, Germany.
²⁷ Institute of Medical Informatics, Biometry, and Epidemiology, University of Munich, Munich, Germany.
²⁸ Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität, Munich, Germany.

PMID: 27562771
DOI: 10.1007/s00702-016-1602-x

No abstract available

PubMed Disclaimer

Erratum for

The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
Levin J, Maaß S, Schuberth M, Respondek G, Paul F, Mansmann U, Oertel WH, Lorenzl S, Krismer F, Seppi K, Poewe W, Wenning G; PROMESA study group; Giese A, Bötzel K, Höglinger G. Levin J, et al. J Neural Transm (Vienna). 2016 Apr;123(4):439-45. doi: 10.1007/s00702-016-1507-8. Epub 2016 Jan 25. J Neural Transm (Vienna). 2016. PMID: 26809243 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach

Affiliations

Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources